Ignite Creation Date:
2025-12-24 @ 3:20 PM
Ignite Modification Date:
2026-05-20 @ 6:04 AM
Study NCT ID:
NCT01068392
Status:
COMPLETED
Last Update Posted:
2014-11-04
First Post:
2010-02-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Oxaliplatin and Prednisolone (Ox-P) for Patients With Relapsed or Refractory Marginal Zone B-cell Lymphoma(MZL)
Sponsor:
Dong-A University Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CISL-MZL-10-3
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None